Zev Wainberg

16PUBLICATIONS
128CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsNutritional epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Mar 30, 2026
Quemliclustat and chemotherapy with or without zimberelimab in metastatic pancreatic adenocarcinoma: a randomized phase 1 trial.

Zev A Wainberg, Gulam A Manji, Nathan Bahary

|Mar 23, 2026
The Randomized Phase II ARC-9 Study of Etrumadenant-Based Therapy versus Regorafenib in Patients with Previously Treated Metastatic Colorectal Cancer.

Michael Cecchini, Sae-Won Han, Soohyeon Lee

|Jan 31, 2026
Neoadjuvant modified FOLFIRINOX plus nivolumab in borderline-resectable pancreatic ductal adenocarcinoma: a pilot phase 1 trial.

Zev A Wainberg, Jason M Link, Alykhan Premji

|May 31, 2025
Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study.

Kohei Shitara, Sylvie Lorenzen, Jin Li

|Mar 21, 2025
Genomic Landscape of Late-Stage Gastric Cancer: Analysis From KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Studies.

Yelena Y Janjigian, Michael Cecchini, Kohei Shitara

|Jan 24, 2025
Prevalence of FGFR2b Protein Overexpression in Advanced Gastric Cancers During Prescreening for the Phase III FORTITUDE-101 Trial.

Sun Young Rha, Yanqiao Zhang, Anneli Elme

Pageof 3

Frequent Collaborators

7 joint publications

Kohei Shitara

4 joint publications

Yelena Y Janjigian

3 joint publications

Anwaar Saeed

3 joint publications

Jaffer Ajani